Role of p53/p21Waf1/Cip1 in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells

Yi Huang, Allison Pledgie, Ethel Rubin, Laurence J. Marton, Patrick M. Woster, Saraswati Sukumar, Robert A Casero, Nancy E. Davidson

Research output: Contribution to journalArticle

Abstract

Intracellular polyamines are absolutely required for cell proliferation and many tumors have abnormal requirements for polyamines. Therefore, the polyamine metabolic pathway represents a rational target for antineoplastic intervention. A number of polyamine analogues act as potent modulators of cellular polyamine metabolism and exhibit encouraging effects against tumor growth in both cell culture and animal studies. In this study we demonstrate that specific polyamine analogues exhibit differential inhibitory action against growth of human breast cancer MCF-7 cells. Treatment of MCF-7 cells with oligoamine analogues and the symmetrically substituted bis(alkyl)-substituted analogue, BENSpm, produced a G1 cell cycle arrest, while the unsymmetrically substituted bis(alkyl)-substituted analogue, CHENSpm, induced a G2/M cell cycle arrest. All four compounds significantly upregulated p53 and p21 expression in MCF-7 cells. Stable transfection of small interfering RNA (siRNA) targeting p53 blocked the expression of p21 induced by the polyamine analogues and significantly reduced polyamine analogue-induced growth inhibition and apoptosis, suggesting that polyamine analogue-induced p21 expression occurs through p53-dependent mechanisms. The effects of analogue exposure on cyclins and cyclin dependent kinases varied with the specific agent used. Expression of p53 siRNA reversed only BENSpm-modulated the cell cycle arrest, suggesting that regulation of cell cycle arrest by p53/p21 induced by polyamine analogues occurs through agent-specific mechanisms. Understanding the mechanism of p53-mediated cellular responses to polyamine analogue may help to improve the therapeutic efficacy of polyamine analogues in human breast cancer.

Original languageEnglish (US)
Pages (from-to)1006-1013
Number of pages8
JournalCancer Biology and Therapy
Volume4
Issue number9
StatePublished - Sep 2005

Fingerprint

Polyamines
Cell Death
Breast Neoplasms
Growth
MCF-7 Cells
Cell Cycle Checkpoints
Small Interfering RNA
G2 Phase Cell Cycle Checkpoints
G1 Phase Cell Cycle Checkpoints
Cyclins
Cyclin-Dependent Kinases
Metabolic Networks and Pathways
Antineoplastic Agents
Transfection
Neoplasms
Cell Culture Techniques
Cell Proliferation
Apoptosis

Keywords

  • Breast cancer cells
  • Cell cycle arrest
  • Cell death
  • p53/p21
  • Polyamine analogues

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Role of p53/p21Waf1/Cip1 in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells. / Huang, Yi; Pledgie, Allison; Rubin, Ethel; Marton, Laurence J.; Woster, Patrick M.; Sukumar, Saraswati; Casero, Robert A; Davidson, Nancy E.

In: Cancer Biology and Therapy, Vol. 4, No. 9, 09.2005, p. 1006-1013.

Research output: Contribution to journalArticle

Huang, Yi ; Pledgie, Allison ; Rubin, Ethel ; Marton, Laurence J. ; Woster, Patrick M. ; Sukumar, Saraswati ; Casero, Robert A ; Davidson, Nancy E. / Role of p53/p21Waf1/Cip1 in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells. In: Cancer Biology and Therapy. 2005 ; Vol. 4, No. 9. pp. 1006-1013.
@article{c30062d648cc4cb695b8c717a9e1b547,
title = "Role of p53/p21Waf1/Cip1 in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells",
abstract = "Intracellular polyamines are absolutely required for cell proliferation and many tumors have abnormal requirements for polyamines. Therefore, the polyamine metabolic pathway represents a rational target for antineoplastic intervention. A number of polyamine analogues act as potent modulators of cellular polyamine metabolism and exhibit encouraging effects against tumor growth in both cell culture and animal studies. In this study we demonstrate that specific polyamine analogues exhibit differential inhibitory action against growth of human breast cancer MCF-7 cells. Treatment of MCF-7 cells with oligoamine analogues and the symmetrically substituted bis(alkyl)-substituted analogue, BENSpm, produced a G1 cell cycle arrest, while the unsymmetrically substituted bis(alkyl)-substituted analogue, CHENSpm, induced a G2/M cell cycle arrest. All four compounds significantly upregulated p53 and p21 expression in MCF-7 cells. Stable transfection of small interfering RNA (siRNA) targeting p53 blocked the expression of p21 induced by the polyamine analogues and significantly reduced polyamine analogue-induced growth inhibition and apoptosis, suggesting that polyamine analogue-induced p21 expression occurs through p53-dependent mechanisms. The effects of analogue exposure on cyclins and cyclin dependent kinases varied with the specific agent used. Expression of p53 siRNA reversed only BENSpm-modulated the cell cycle arrest, suggesting that regulation of cell cycle arrest by p53/p21 induced by polyamine analogues occurs through agent-specific mechanisms. Understanding the mechanism of p53-mediated cellular responses to polyamine analogue may help to improve the therapeutic efficacy of polyamine analogues in human breast cancer.",
keywords = "Breast cancer cells, Cell cycle arrest, Cell death, p53/p21, Polyamine analogues",
author = "Yi Huang and Allison Pledgie and Ethel Rubin and Marton, {Laurence J.} and Woster, {Patrick M.} and Saraswati Sukumar and Casero, {Robert A} and Davidson, {Nancy E.}",
year = "2005",
month = "9",
language = "English (US)",
volume = "4",
pages = "1006--1013",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "9",

}

TY - JOUR

T1 - Role of p53/p21Waf1/Cip1 in the regulation of polyamine analogue-induced growth inhibition and cell death in human breast cancer cells

AU - Huang, Yi

AU - Pledgie, Allison

AU - Rubin, Ethel

AU - Marton, Laurence J.

AU - Woster, Patrick M.

AU - Sukumar, Saraswati

AU - Casero, Robert A

AU - Davidson, Nancy E.

PY - 2005/9

Y1 - 2005/9

N2 - Intracellular polyamines are absolutely required for cell proliferation and many tumors have abnormal requirements for polyamines. Therefore, the polyamine metabolic pathway represents a rational target for antineoplastic intervention. A number of polyamine analogues act as potent modulators of cellular polyamine metabolism and exhibit encouraging effects against tumor growth in both cell culture and animal studies. In this study we demonstrate that specific polyamine analogues exhibit differential inhibitory action against growth of human breast cancer MCF-7 cells. Treatment of MCF-7 cells with oligoamine analogues and the symmetrically substituted bis(alkyl)-substituted analogue, BENSpm, produced a G1 cell cycle arrest, while the unsymmetrically substituted bis(alkyl)-substituted analogue, CHENSpm, induced a G2/M cell cycle arrest. All four compounds significantly upregulated p53 and p21 expression in MCF-7 cells. Stable transfection of small interfering RNA (siRNA) targeting p53 blocked the expression of p21 induced by the polyamine analogues and significantly reduced polyamine analogue-induced growth inhibition and apoptosis, suggesting that polyamine analogue-induced p21 expression occurs through p53-dependent mechanisms. The effects of analogue exposure on cyclins and cyclin dependent kinases varied with the specific agent used. Expression of p53 siRNA reversed only BENSpm-modulated the cell cycle arrest, suggesting that regulation of cell cycle arrest by p53/p21 induced by polyamine analogues occurs through agent-specific mechanisms. Understanding the mechanism of p53-mediated cellular responses to polyamine analogue may help to improve the therapeutic efficacy of polyamine analogues in human breast cancer.

AB - Intracellular polyamines are absolutely required for cell proliferation and many tumors have abnormal requirements for polyamines. Therefore, the polyamine metabolic pathway represents a rational target for antineoplastic intervention. A number of polyamine analogues act as potent modulators of cellular polyamine metabolism and exhibit encouraging effects against tumor growth in both cell culture and animal studies. In this study we demonstrate that specific polyamine analogues exhibit differential inhibitory action against growth of human breast cancer MCF-7 cells. Treatment of MCF-7 cells with oligoamine analogues and the symmetrically substituted bis(alkyl)-substituted analogue, BENSpm, produced a G1 cell cycle arrest, while the unsymmetrically substituted bis(alkyl)-substituted analogue, CHENSpm, induced a G2/M cell cycle arrest. All four compounds significantly upregulated p53 and p21 expression in MCF-7 cells. Stable transfection of small interfering RNA (siRNA) targeting p53 blocked the expression of p21 induced by the polyamine analogues and significantly reduced polyamine analogue-induced growth inhibition and apoptosis, suggesting that polyamine analogue-induced p21 expression occurs through p53-dependent mechanisms. The effects of analogue exposure on cyclins and cyclin dependent kinases varied with the specific agent used. Expression of p53 siRNA reversed only BENSpm-modulated the cell cycle arrest, suggesting that regulation of cell cycle arrest by p53/p21 induced by polyamine analogues occurs through agent-specific mechanisms. Understanding the mechanism of p53-mediated cellular responses to polyamine analogue may help to improve the therapeutic efficacy of polyamine analogues in human breast cancer.

KW - Breast cancer cells

KW - Cell cycle arrest

KW - Cell death

KW - p53/p21

KW - Polyamine analogues

UR - http://www.scopus.com/inward/record.url?scp=27744446124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744446124&partnerID=8YFLogxK

M3 - Article

C2 - 16131835

AN - SCOPUS:27744446124

VL - 4

SP - 1006

EP - 1013

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 9

ER -